Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) Gross Profit (2020 - 2025)

Historic Gross Profit for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $12.9 million.

  • SOPHiA GENETICS's Gross Profit rose 2114.7% to $12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.5 million, marking a year-over-year increase of 1315.71%. This contributed to the annual value of $43.9 million for FY2024, which is 238.62% up from last year.
  • SOPHiA GENETICS's Gross Profit amounted to $12.9 million in Q3 2025, which was up 2114.7% from $12.3 million recorded in Q2 2025.
  • SOPHiA GENETICS's 5-year Gross Profit high stood at $6230.0 billion for Q2 2021, and its period low was $5.6 million during Q1 2021.
  • Its 5-year average for Gross Profit is $327.9 billion, with a median of $10.4 million in 2024.
  • As far as peak fluctuations go, SOPHiA GENETICS's Gross Profit skyrocketed by 15698522.44% in 2021, and later tumbled by 9999.99% in 2022.
  • SOPHiA GENETICS's Gross Profit (Quarter) stood at $6.8 million in 2021, then soared by 41.01% to $9.6 million in 2022, then grew by 23.54% to $11.9 million in 2023, then grew by 1.71% to $12.1 million in 2024, then increased by 6.65% to $12.9 million in 2025.
  • Its last three reported values are $12.9 million in Q3 2025, $12.3 million for Q2 2025, and $12.2 million during Q1 2025.